NPM1P17

Across TCGA pan-cancer cohorts, NPM1P17 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of NPM1P17’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where NPM1P17 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types NPM1P17 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

LUAD and THCA are the cancer types where NPM1P17 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in NPM1P17 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	II,III,IV	+0.025	.042	1	view →
THCA	All	II,III,IV	−0.024	.046	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

NPM1P17–LUAD

Open the LUAD breakdown →